large-scale awareness, better treatment of prostate lowest death rate from cancer

large-scale awareness, better treatment of prostate lowest death rate from cancer -

Less than men are diagnosed with and dying from prostate cancer these days. While this is partly due to wider awareness and better treatment, it is also the result of a more appropriate screening.

Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths in men after lung cancer. In 1995, when a test is to measure out the PSA, or the specific antigen of the prostate, in the blood, the number of enhanced diagnostics. Over the past 20 years - in particular the past five or six -. There was an annual reduction of 3 to 4 percent of diagnoses

awareness certainly plays a role in this regard. Most men know they must get tested once a year or once they have reached 50 years because early detection leads to more effective treatment.

"If you are under 50, you are at low risk, and if you 're over 70, you'll probably die of another cause," says Dr. Jay Raman, associate professor urology at Penn State Hershey

the people most at risk are men whose father or brother. was diagnosed, and African-American men and those who eat diets rich in fat have been known to increase the risk of developing other cancers.

Raman said there is discussion in the medical community about the need and frequency of the projections of the prostate.

it there

a little more than two years, the working Group of the US prevention services gave a bad score for the screening of prostate cancer, indicating the absence of general interest to him. the position of the American Urological Association suggested that it was a bit extreme and that men still need to be examined, just a more effective way

New, more specific tests have been developed - . with PSA and a rectal exam - can determine the type, quantity and aggressiveness of prostate cancer. Raman said a recent urinary PCA3 test is right for potentially confirm a higher initial PSA value prior to prostate biopsy.

"We now know that all cancer is prostate as well," he said. "Some may be simply followed and observed and do not require active treatment."

The progress of surgery in the past five to 10 years, coupled with a more targeted radiation and new drugs approved by the Food and Drug Administration has also contributed to lower mortality rates of cancer prostate once diagnosed.

Raman said the bottom line is to be aware, but do not over treat.

"screening is important because it can detect the disease before it becomes large enough to be symptomatic," he said. "But just as you do not start medication immediately after against diabetes one high glucose test, you do not want to overreact to a single high PSA result. "